Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

Keywords

ApixabanMedicineWarfarinVitamin K antagonistAtrial fibrillationStroke (engine)Clinical endpointInternal medicineCardiologyEmbolismRandomized controlled trialPlaceboAnesthesiaRivaroxaban

Affiliated Institutions

Related Publications

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Gerhard Hindricks , Tatjana Potpara , Nikolaos Dagres +81 more

International audience

2020 European Heart Journal 9354 citations

Natural History of Asymptomatic Mitral Valve Prolapse in the Community

Jean-François Aviérinos , Bernard J. Gersh , L. Joseph Melton +5 more

Background— The outcome of mitral valve prolapse (MVP) is controversial, with marked discrepancies in reported complication rates. Methods and Results— We conducted a community ...

2002 Circulation 438 citations

Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke

François Gueyffier , Jean‐Pierre Boissel , Florent Boutitie +10 more

Background and Purpose Drug treatment of high blood pressure has been shown to reduce the associated cardiovascular risk. Stroke represents the type of event more strongly linke...

1997 Stroke 247 citations

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.

S L Spector , Lewis J. Smith , Mitchell Glass

The efficacy of 6 wk of therapy with oral ICI 204,219, a selective leukotriene D4 (LTD4) receptor antagonist, was evaluated in subjects with moderate asthma during a multicenter...

1994 American Journal of Respiratory and C... 345 citations

Glucose Potassium Insulin Infusions in the Treatment of Acute Stroke Patients With Mild to Moderate Hyperglycemia

Jon Scott , Gina M Robinson , JOYCE M. FRENCH +3 more

Background and Purpose —Hyperglycemia following acute stroke is strongly associated with subsequent mortality and impaired neurological recovery, but it is unknown whether maint...

1999 Stroke 269 citations

Publication Info

Year: 2010
Type: article
Volume: 159
Issue: 3
Pages: 331-339
Citations: 453
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

453

OpenAlex

Cite This

APA Style

                            
                                
                                    Renato D. Lópes, 
                                
                                    John H. Alexander, 
                                
                                    Sana M. Al‐Khatib
                                
                                et al.
                            
                            (2010). 
                            Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale. 
                            American Heart Journal
                            , 159
                            (3)
                            , 331-339.
                            https://doi.org/10.1016/j.ahj.2009.07.035
                        

Identifiers

DOI: 10.1016/j.ahj.2009.07.035